Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - salbutamol sulfate 0.482 mg/ml equivalent to salbutamol 0.4 mg/ml - syrup - 2 mg/5ml - active: salbutamol sulfate 0.482 mg/ml equivalent to salbutamol 0.4 mg/ml excipient: citric acid glycerol purified water raspberry flavour 517503e saccharin sodium sodium benzoate sodium citrate dihydrate xanthan gum - indicated for relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - salbutamol sulfate 0.482 mg/ml (eqv to 0.4mg/ml of salbutamol) - syrup - 2 mg/5ml - active: salbutamol sulfate 0.482 mg/ml (eqv to 0.4mg/ml of salbutamol) excipient: citric acid monohydrate glycerol purified water raspberry flavour 517503e saccharin sodium sodium benzoate sodium citrate dihydrate xanthan gum - salapin is indicated for relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema. salapin is suitable oral therapy for children or those adults who prefer liquid medicines.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: sulfuric acid; water for injections; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - salbutamol sulfate -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - salbutamol sulfate -

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

neutec inhaler ireland limited - salbutamol sulfate - nebuliser solution - salbutamol

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - inhalation - excipient ingredients: water for injections; sodium chloride; sulfuric acid - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.